Enzymotec Ltd. (ENZY) was a big mover last session, as the company saw its shares rise a little over 11% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 16.5% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Enzymotec currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Other players in the healthcare industry which carry the same rank as Enzymotec include Myriad Genetics Inc. (MYGN), ANI Pharmaceuticals, Inc. (ANIP and Aastrom Biosciences, Inc. (ASTM) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment